Laurie Toich, Assistant Editor

These findings could lead to novel a HIV vaccine.

Ademlog (insulin lispro injection) approved to control blood glucose levels among patients with diabetes.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Diplomat Pharmacy Inc.’s Acquisition of National Pharmaceutical Services will improve patient management services.

Online consultations may reduce the need for in-person appointments, but challenges can still arise.

Ibrutinib (Imbruvica) plus rituximab increased progression-free survival among patients with Waldenström's macroglobulinemia.

Nearly 30,000 individuals were diagnosed with HIV in the European Region in 2016.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Top articles of the week from The American Journal of Pharmacy Benefits.

Patients with cancer and caregivers said that the internet helped them to make informed care-related decisions.

An investigational HIV drug may be able to cross the blood-brain barrier and prevent adverse events.

PD-L1-based immunotherapy observed to elicit long-lasting diabetes reversal in mice.

Diabetics using continuous glucose monitors were more aware of their blood sugar levels.

Pharmacists may be the most efficient health care professionals when it comes to preventing medication errors.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Medication histories taken by pharmacists and pharmacy technicians significantly reduced medication errors.

Starting an adherence program for patients with HIV may mitigate costs for universal treatment protocols.

Up to 90% of patients with psoriasis develop plaque on their nails, palms of the hands, and soles of the feet.

Cell structure may allow immune cells to attack myelin in multiple sclerosis.

Pulse oximetry found to reduce infant death from congenital heart disease by 33%.

Bevacizumab (Avastin) previously received provisional approval from the FDA.

Value-based reimbursement could help lower specialty drug costs.

A new report suggests Amazon is in talks with Mylan and Sandoz.

Another study suggests gut bacteria has an important role in triggering multiple sclerosis.

Enhanced obesity prevention services needed during very early childhood.

The FDA previously found that PD-1/PD-L1 inhibitors may increase the mortality risk for patients with multiple myeloma.

Top news of the day from across the healthcare landscape.